{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:44:58Z","timestamp":1759333498223},"publisher-location":"Berlin, Heidelberg","reference-count":48,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642787737"},{"type":"electronic","value":"9783642787713"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/978-3-642-78771-3_17","type":"book-chapter","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T01:07:40Z","timestamp":1321837660000},"page":"225-237","source":"Crossref","is-referenced-by-count":5,"title":["New Perspectives in Experimental and Clinical Research for Cutaneous T Cell Lymphomas"],"prefix":"10.1007","author":[{"given":"G.","family":"Burg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"H\u00e4ffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"B\u00f6ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dommann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/0190-9622(90)70074-R","volume":"22","author":"BA Agnarsson","year":"1990","unstructured":"Agnarsson BA, Vonderheid EC, Kadin ME (1990) Cutaneous T cell lymphoma with suppressor\/eytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 22:569\u2013577","journal-title":"J Am Acad Dermatol"},{"key":"17_CR2","first-page":"109","volume":"2","author":"M Alaibac","year":"1992","unstructured":"Alaibac M, Chu AC (1992) Pagetoid reticulosis: a gamma\/-delta T-cell lymphoma? Eur J Dermatol 2:109\u2013111","journal-title":"Eur J Dermatol"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1001\/archderm.128.12.1602","volume":"128","author":"V Bakels","year":"1992","unstructured":"Bakels V, van Oostveen J, Gordijn L, Walboomers J, Meijer C, Willemze R (1992) Frequency and prognostic significance of clonal T-cell receptor beta gene rearrangements in the peripheral blood of patients with mycosis fungoides. Arch Dermatol 128:1602\u20131607","journal-title":"Arch Dermatol"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/S0140-6736(89)92455-0","volume":"1","author":"FR Balkwill","year":"1989","unstructured":"Balkwill FR (1989) Interferons. Lancet 1:1060\u20131063","journal-title":"Interferons. Lancet"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000247579","volume":"184","author":"G Burg","year":"1992","unstructured":"Burg G, Schm\u00f6ckel CH (1992) Syringolymphoid hyperplasia with alopecia. A syringotropic cutaneous T-cell lymphoma? Dermatology 184:306\u2013307","journal-title":"Dermatology"},{"key":"17_CR6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0733-8635(18)30866-0","volume":"3","author":"G Burg","year":"1985","unstructured":"Burg G, Kaudewitz P, Klepzig K, Przybilla B, Braun-Falco O (1985) Cutaneous B-cell lymphoma. Dermatol Clin 3:689\u2013704","journal-title":"Dermatol Clin"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJM199110103251506","volume":"325","author":"G Burg","year":"1991","unstructured":"Burg G, Dummer R, Wilhelm M, Nestle F, Ott MM, Feller A, Hefner H, Lanz U, Schwinn A, Wiede J (1991) A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med 325:1078\u20131081","journal-title":"N Engl J Med"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0733-8635(18)30169-4","volume":"12","author":"G Burg","year":"1994","unstructured":"Burg G, Dummer R, Kerl H (1994) Classification of cutaneous lymphomas. Dermatol Clin 12:213\u2013217","journal-title":"Dermatol Clin"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0167-5699(88)91233-9","volume":"9","author":"L Carter","year":"1988","unstructured":"Carter L, DenHollander N, Ramaswamy K, Riley D, Befus D (1988) Expression of TCR types on gut intraepithelial lymphocytes. Immunol Today 9:368\u2013369","journal-title":"Immunol Today"},{"key":"17_CR10","unstructured":"Dommann S, Dommann-Scherrer CC, Burg G. Cutaneous T-cell rich large B-cell lymphoma, (submitted for publication)"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2133.1991.tb14772.x","volume":"125","author":"B Dreno","year":"1991","unstructured":"Dreno B, Claudy A, Meynadier J, Verret JL, Souteyrand P, Ortonne JP, Kalis B, Godefroy WY, Beerblock K, Thill L (1991) The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-alpha 2a and etretinate. Br J Dermatol 125:456\u2013459","journal-title":"Br J Dermatol"},{"key":"17_CR12","first-page":"135","volume":"1","author":"R Dummer","year":"1991","unstructured":"Dummer R, Nestle F, Wiede J, Sch\u00e4fer E, R\u00f6ger J, Erhard H, Hefner H, Burg G (1991) Coincidence of increased soluble interleukin-2 receptors, diminished natural killer cell activity and progressive disease in cutaneous T-cell lymphomas. Eur J Dermatol 1:135\u2013138","journal-title":"Eur J Dermatol"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/1523-1747.ep12494223","volume":"98","author":"R Dummer","year":"1992","unstructured":"Dummer R, Posseckert G, Nestle F, Witzgall R, Burger M, Becker JC, Sch\u00e4fer E, Wiede J, Sebald W, Burg G (1992) Soluble interleukin-2 receptors inhibit interleukin-2 dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? J Invest Dermatol 98:50\u201354","journal-title":"J Invest Dermatol"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1002\/1097-0142(19930601)71:11<3793::AID-CNCR2820711153>3.0.CO;2-C","volume":"71","author":"R Dummer","year":"1993","unstructured":"Dummer R, Burg G, Nestle F, Kohl O (1993a) Soluble interleukin-2 receptor and cutaneous T-cell lymphoma. Cancer 71:3793\u20133794","journal-title":"Cancer"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/archderm.129.4.433","volume":"129","author":"R Dummer","year":"1993","unstructured":"Dummer R, Kohl O, Gillisson J, K\u00e4gi M, Burg G (1993b) Peripheral blood mononuclear cells in non-leukemic cutaneous T-cell lymphoma patients: reduced proliferation and preferential secretion of a T helper 2 like cytokine pattern upon stimulation Arch Dermatol 129:433\u2013436","journal-title":"Arch Dermatol"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/0190-9622(93)70275-X","volume":"29","author":"R Dummer","year":"1993","unstructured":"Dummer R, Krasovec M, Roger J, Sindermann H, Burg G (1993c) Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. J Am Acad Dermatol 29:963\u2013970","journal-title":"J Am Acad Dermatol"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/1523-1747.ep12514722","volume":"96","author":"SG Gilmore","year":"1991","unstructured":"Gilmore SG, Benson EM, Kelly JW (1991) T-cell subsets with a naive phenotype are selectively decreased in the peripheral blood of patients with mycosis fungoides. J Invest Dermatol 96:50\u201356","journal-title":"J Invest Dermatol"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00000478-199101000-00002","volume":"15","author":"CL Gonzalez","year":"1991","unstructured":"Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES (1991) T-cell lymphoma involving subcutaneous tissue: a clinico-pathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 15:17\u201327","journal-title":"Am J Surg Pathol"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/0190-9622(92)70125-Y","volume":"26","author":"P Heald","year":"1992","unstructured":"Heald P, Buckley P, Gilliam A, Perez M, Knobler R, Kacinski B, Edelson R (1992) Correlations of unique clinical, immunotypic, and histologic findings in cutaneous gamma\/delta T-cell lymphoma. J Am Acad Dermatol 26:865\u2013870","journal-title":"J Am Acad Dermatol"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0167-5699(90)90173-7","volume":"11","author":"T Hirano","year":"1990","unstructured":"Hirano T, Akira S, Taga T, Kishimoto T (1990) Biological and clinical aspects of interleukin-6. Immunol Today 11:443\u2013449","journal-title":"Immunol Today"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/1097-0142(19890415)63:8<1612::AID-CNCR2820630828>3.0.CO;2-C","volume":"63","author":"AF Kantor","year":"1989","unstructured":"Kantor AF, Curtis RE, Vonderheid EC, van Scott EJ, Fraumeni JF (1989) Risk of second malignancy after cutaneous T-cell lymphoma. Cancer 63:1612\u20131615","journal-title":"Cancer"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","volume":"321","author":"FJ Kaye","year":"1989","unstructured":"Kaye FJ, Bunn PJ, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM et al (1989) A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 321:1784\u20131790","journal-title":"N Engl J Med"},{"key":"17_CR23","first-page":"55","volume":"8","author":"H Kerl","year":"1991","unstructured":"Kerl H, Cerroni L, Burg G (1991) The morphologic spectrum of T-cell lymphomas of the skin: a proposal for a new classification. Semin Diagn Pathol 8:55\u201361","journal-title":"Semin Diagn Pathol"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0190-9622(91)70036-2","volume":"24","author":"RM Knobler","year":"1991","unstructured":"Knobler RM, Trautinger F, Radaszkiewicz T, Kokoschka EM, Micksche M (1991) Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. J Am Acad Dermatol 24:247\u2013252","journal-title":"J Am Acad Dermatol"},{"key":"17_CR25","first-page":"101","volume":"308","author":"L Laroche","year":"1983","unstructured":"Laroche L, Kaiserling D (1983) Decreased natural-killer cell activity in cutaneous T-cell lymphomas. N Engl J Med 308:101\u2013102","journal-title":"N Engl J Med"},{"key":"17_CR26","first-page":"73","volume":"8","author":"PE LeBoit","year":"1991","unstructured":"LeBoit PE (1991) Variants of mycosis fungoides and related cutaneous T-cell lymphomas. Semin Diagn Pathol 8:73\u201381","journal-title":"Semin Diagn Pathol"},{"key":"17_CR27","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-97187-7","volume-title":"Histopathology of non-Hodgkin\u2019s lymphomas","author":"K Lennert","year":"1992","unstructured":"Lennert K, Feller AC (1992) Histopathology of non-Hodgkin\u2019s lymphomas. Springer, Berlin Heidelberg New York"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0167-5699(92)90199-H","volume":"13","author":"YJ Liu","year":"1992","unstructured":"Liu YJ, Johnson GD, Gordon J, MacLennan ICM (1992) Germinal centers in T-cell-dependent antibody responses. Immunol Today 13:17\u201321","journal-title":"Immunol Today"},{"key":"17_CR29","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","volume":"136","author":"TR Mosmann","year":"1986","unstructured":"Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348\u20132357","journal-title":"J Immunol"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0625.1992.tb00069.x","volume":"1","author":"E Ralfkiaer","year":"1992","unstructured":"Ralfkiaer E, Wollf-Sneedorff A, Thomsen K, Geisler C, Vejlsgaard G (1992) T-cell receptor gamma\/delta-positive peripheral T-cell lymphomas presenting in the skin: a clinical, histological and immunophenotypic study. Exp Dermatol 1:31 \u2013 36","journal-title":"Exp Dermatol"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00000478-198806000-00003","volume":"12","author":"AD Ramsay","year":"1988","unstructured":"Ramsay AD, Smith WJ, Isaacson PG (1988) T-cell-rich B-cell lymphoma. Am J Surg Pathol 12:433\u2013443","journal-title":"Am J Surg Pathol"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/1097-0142(19911115)68:10<2155::AID-CNCR2820681012>3.0.CO;2-Y","volume":"68","author":"U Reinhold","year":"1991","unstructured":"Reinhold U, Abken H, Kukel S, Goeden B, Uerlich M, Neumann U, Kreysel HW (1991) Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion. Cancer 68:2155\u20132160","journal-title":"Cancer"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"198S","DOI":"10.1111\/1523-1747.ep12875523","volume":"95","author":"H Roenigk","year":"1990","unstructured":"Roenigk H, Kuzel TM, Skoutelis AP, Springer E, Yu G, Caro W, Gilyon K, Variakojis D, Kaul K, Bunn PJ et al (1990) Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 95:198S\u2013205S","journal-title":"J Invest Dermatol"},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0190-9622(81)70032-X","volume":"4","author":"HJ Roenigk","year":"1981","unstructured":"Roenigk HJ, Caro WA (1981) Skin cancer in the PUVA-48 cooperative study. J Am Acad Dermatol 4:319\u2013324","journal-title":"J Am Acad Dermatol"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/0167-5699(91)90120-I","volume":"12","author":"S Romagnani","year":"1991","unstructured":"Romagnani S (1991) Human TH1 and TH2 subsets: doubt no more. Immunol Today 12:256\u2013257","journal-title":"Immunol Today"},{"key":"17_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0167-5699(88)91212-1","volume":"9","author":"ME Sanders","year":"1988","unstructured":"Sanders ME (1988) Human naive and memory T-cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 9:195\u2013198","journal-title":"Immunol Today"},{"issue":"abstr","key":"17_CR37","first-page":"100","volume":"458","author":"G Staib","year":"1993","unstructured":"Staib G, Mielke V, Griesser H, Menke M, Duller B, Sterry W (1993) PCR-analysis of T-cell receptor (TCR)-gamma genes to differentiate between malignant and reactive T-cell infiltrates of the skin. J Invest Dermatol 100:458 (abstr)","journal-title":"J Invest Dermatol"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","volume":"11","author":"A Stansfeld","year":"1988","unstructured":"Stansfeld A, Diebold J, Kapanci Y (1988) Updated Kiel classification for lymphomas. Lancet 11:292\u2013293","journal-title":"Lancet"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/1523-1747.ep12494184","volume":"98","author":"Y Tokura","year":"1992","unstructured":"Tokura Y, Heald PW, Yan SL, Edelson RL (1992) Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. J Invest Dermatol 98:33\u201337","journal-title":"J Invest Dermatol"},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archderm.124.3.373","volume":"124","author":"SCJ Putte van der","year":"1988","unstructured":"van der Putte SCJ, Toonstra J, van Wichen DF, van Unnik JAM, van Vloten W (1988) Abberant immunophenotype in mycosis fungoides. Arch Dermatol 124: 373\u2013380","journal-title":"Arch Dermatol"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0190-9622(84)70208-8","volume":"11","author":"PY Venencie","year":"1984","unstructured":"Venencie PY, Winkelmann RK, Friedman SJ, Kyle RA, Puissant A (1984) monoclonal gammopathy and mycosis fungoides. J Am Acad Dermatol 11:576\u2013579","journal-title":"J Am Acad Dermatol"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/1523-1747.ep12365889","volume":"101","author":"M Volkenandt","year":"1993","unstructured":"Volkenandt M, Wienecke R, Koch O, Buer J, Probst M, Atzpodien J, Horishi T, Danenberg K, Danenberg P, Bertino J (1993) Conformational polymorphisms of cRNA of T-cell receptor genes as a clone-specific marker for cutaneous lymphoma. J Invest Dermatol 101:514\u2013516","journal-title":"J Invest Dermatol"},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/BF00200536","volume":"13","author":"GS Wood","year":"1992","unstructured":"Wood GS (1992) Cutaneous lymphoproliferative disorders: strategies for molecular biological analysis and their major findings. Springer Semin Immunopathol 13: 387\u2013399","journal-title":"Springer Semin Immunopathol"},{"key":"17_CR44","doi-asserted-by":"crossref","unstructured":"Wood GS, Haeffner AC, Dummer R, Crooks C (1994) Molecular biology techniques for the diagnosis of CTCL. Dermatol Clin (in press)","DOI":"10.1016\/S0733-8635(18)30171-2"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/archderm.126.7.907","volume":"126","author":"NL Wood","year":"1990","unstructured":"Wood NL, Kitces EN, Blaylock K (1990) Depressed lymphokine activated killer cell activity in mycosis fungoides. Arch Dermatol 126:907\u2013913","journal-title":"Arch Dermatol"},{"key":"17_CR46","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","author":"Working Formulation","year":"1982","unstructured":"Working Formulation (1982) The non-Hodgkin\u2019s lymphoma pathologic classification project. National Cancer Institute sponsored study of classification of non-Hodgkin\u2019s lymphoma. Summary and description of Working Formulation for clinical usage. Cancer 49:2112\u20132135","journal-title":"Cancer"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"206S","DOI":"10.1111\/1523-1747.ep12875616","volume":"95","author":"H Zachariae","year":"1990","unstructured":"Zachariae H, Thestrup-Pedersen K (1990) Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma. J Invest Dermatol 95:206S\u2013208S","journal-title":"J Invest Dermatol"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/0190-9622(90)70112-U","volume":"22","author":"HS Zackheim","year":"1990","unstructured":"Zackheim HS, Epstein EJ, Crain WR (1990) Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients. J Am Acad Dermatol 22:802\u2013810","journal-title":"J Am Acad Dermatol"}],"container-title":["Recent Results in Cancer Research","Skin Cancer: Basic Science, Clinical Research and Treatment"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-78771-3_17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T03:00:26Z","timestamp":1686452426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-78771-3_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"ISBN":["9783642787737","9783642787713"],"references-count":48,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-78771-3_17","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1995]]}}}